SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Spinal Muscular Atrophy Pipeline Highlights - 2014 Update

[June 25, 2014]

Research and Markets: Spinal Muscular Atrophy Pipeline Highlights - 2014 Update

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/sl8dpz/spinal_muscular) has announced the addition of the "Spinal Muscular Atrophy Pipeline Highlights - 2014 Update" report to their offering.

The latest report "Spinal Muscular Atrophy Pipeline Highlights - 2014 Update" provides most up-to-date information on key pipeline molecules in the global Spinal Muscular Atrophy market. It covers emeging therapies for Spinal Muscular Atrophy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.


Key Topics Covered:

1. Spinal Muscular Atrophy Pipeline by Stages

2. Spinal Muscular Atrophy Pipeline by Drug Class

3. Spinal Muscular Atrophy Pipeline by Company

4. Spinal Muscular Atrophy Phase 3 Clinical Trial Insights

5. Spinal Muscular Atrophy Phase 2 Clinical Trial Insights

6. Spinal Muscular Atrophy Phase 1 Clinical Trial Insights

7. Spinal Muscular Atrophy Preclinical Research Insights

8. Spinal Muscular Atrophy Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/sl8dpz/spinal_muscular


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy